Shridar Ganesan, MD, PhD

Shridar Ganesan, MD, PhD was recruited to Rutgers Cancer Institute of New Jersey in June 2006. He is currently an Associate Professor of Medicine and Pharmacology as well as the Omar Boraie Chair in Genomic Science and serves as Associate Director of Translational Science and is a key member of the leadership team at Rutgers Cancer Institute. He is a respected researcher in cancer biology, a respected teacher and mentor, and a compassionate physician.

Dr. Ganesan graduated from Princeton University summa cum laude, and went on to receive a PhD in Cell Biology and an MD from Yale University.  He trained in internal medicine at the Brigham and Women’s Hospital in Boston, MA, where he served as Chief Medical Resident, and pursued a fellowship in medical oncology at the Dana Farber Cancer Institute. Dr. Ganesan had post-doctoral training in the laboratory of Dr. David Livingston where he studied the biology of BRCA1 breast cancer gene and its role in DNA repair and chromatin modulation. He joined the faculty of Harvard Medical School as an Instructor in Medicine and as a Staff Physician at the Dana Farber Cancer Institute.

When recruited to Rutgers Cancer Institute of New Jersey as a physician-scientist, he set up an independent research laboratory focused on DNA repair, breast cancer biology, and cancer genomics. This work has been highly productive, leading to over 60 publications in journals such as Science, Cell, Cancer Cell, Cancer Research, Nature Structural and Molecular Biology, and has resulted in funding from the National Institutes of Health, the Sidney Kimmel Foundation, the Triple Negative Breast Cancer Foundation, the Century for the Cure, and Hugs for Brady. He is considered an expert in DNA repair and breast cancer biology and has been invited to give lectures at major national and international cancer centers and major clinical and scientific breast cancer meetings including the San Antonio Breast Caner Symposium and the American Association for Cancer Research. He serves as a grant reviewer for the National Cancer Institute and the US Department of Defense, and reviews articles for many scientific journals.

Dr. Ganesan’s clinical work is focused on breast cancers and rare cancers. He sees patients in the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute. He has a special interest in the biology and treatment of triple-negative breast cancers and BRCA1/2 associated breast cancers, and participates in many clinical trials in breast caner. This work has led to several novel findings that are driving both clinical trials and basic cancer research at Rutgers Cancer Institute.

He is a critical driver of the Precision Medicine Initiative at Rutgers Cancer Institute and has developed a research protocol in which patients with rare or difficult to treat cancers undergo targeted genomic sequencing to search for potential treatment options. He has been instrumental in developing the Molecular Tumor Board and the Molecular Therapeutics Clinic, both at Rutgers Cancer Institute.

Dr. Ganesan gives popular lectures on cancer biology to undergraduates, graduate students, medical students and oncology fellows at Princeton University and Rutgers University and serves as a primary research mentor for graduate students and post-doctoral fellows in his laboratory. He serves as the Assistant Director of the Joint MD-Ph.D. program of Rutgers University and Princeton University.

Dr. Ganesan lives in Westfield, NJ with his wife Anushua Sinha and his daughter Gayatri Sinha Ganesan.

 

 

Learn more about Dr. Ganesan:

 

Go to Top